Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.790 +0.070 (+2.57%)
Streaming Delayed Price Updated: 11:43 AM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aytu BioPharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City
Via ACCESS Newswire
News headline image
Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults
Via ACCESS Newswire
News headline image
Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
Via ACCESS Newswire
News headline image
Aytu BioPharma Inc (NASDAQ:AYTU) Reports Q1 2026 Revenue Beat and Progress on EXXUA Launch ↗
Aytu BioPharma posts Q1 revenue beat and narrows loss, fueling investor optimism for its upcoming EXXUA depression drug launch. 
Via Chartmill
News headline image
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
Via ACCESS Newswire
News headline image
Earnings Scheduled For November 13, 2025 ↗
 
Via Benzinga
News headline image
Earnings Outlook For Aytu BioPharma ↗
 
Via Benzinga
News headline image
Insights into Aytu BioPharma's Upcoming Earnings ↗
 
Via Benzinga
News headline image
Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025
Via ACCESS Newswire
News headline image
Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)
Via ACCESS Newswire
News headline image
Aytu BioPharma to Present at Upcoming October 2025 Conferences
Via ACCESS Newswire
News headline image
11 Company Presentations Today at The MicroCap Rodeo Conference
Via ACCESS Newswire
News headline image
Aytu BioPharma to Present at Upcoming September 2025 Conferences
Via ACCESS Newswire
News headline image
Top movers in Wednesday's session ↗
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
Gapping stocks in Wednesday's session ↗
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
What's going on in today's after hours session ↗
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
Aytu BioPharma Inc (NASDAQ:AYTU) Shares Fall on Q4 Revenue and EPS Miss ↗
Aytu BioPharma shares fell after Q4 2025 results missed revenue and EPS estimates. The company remains focused on the upcoming launch of its depression drug, EXXUA, as a key growth catalyst. 
Via Chartmill
News headline image
Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)
Via ACCESS Newswire
News headline image
Aytu BioPharma's Q4 2025 Earnings: Anticipation Mounts Ahead of Key EXXUA Launch
NEW YORK, NY – September 23, 2025 – As the trading day concludes, all eyes in the biopharmaceutical sector are turning to Aytu BioPharma (NASDAQ: AYTU), which is poised to release its fiscal... 
Via MarketMinute
Topics Earnings
Dow Futures Gain Ahead Of Jerome Powell’s Speech: BA, HOLO, BETR, CLSK Among Stocks To Watch ↗
Via Stocktwits
Topics Economy Stocks
News headline image
Earnings Scheduled For September 23, 2025 ↗
 
Via Benzinga
News headline image
Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
This Starbucks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.